Latest filing published 21 May 2007 for Armata Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -63.7%Entry US$40.80 · Close at T+365 US$14.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jack L. Bowman: trading record in brief
Jack L. Bowman has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Celgene Corp /DE/, Armata Pharmaceuticals, Inc. and Sarepta Therapeutics, Inc. In total, 14 filings cover trades dated from 2 February 2006 to 17 May 2007.
Both buying and selling appear: 1 purchase worth €26k, against 6 sales worth €9.1M. The net balance comes to €9.1M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant and 6 option exercises. In 2007 alone, the filings show no purchases and 2 sales.
The latest filing, published on 21 May 2007, reports a share grant in Armata Pharmaceuticals, Inc. The last insider purchase was made public on 21 March 2006, 7,538 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jack L. Bowman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares0Common StockSEC:0001209191-07-031892:0
- 40,000 shares@ US$8.41Common StockSEC:0000930413-07-004268:0
- 40,000 shares@ US$62.76Common StockSEC:0000930413-07-004268:1
- 40,000 shares@ US$8.41Common StockSEC:0000930413-07-001116:0
- 40,000 shares@ US$55.66Common StockSEC:0000930413-07-001116:1
- 40,000 shares@ US$7.70Common StockSEC:0000930413-06-007571:0
- 40,000 shares@ US$49.42Common StockSEC:0000930413-06-007571:1
- 40,000 shares@ US$4.41Common StockSEC:0000930413-06-005542:0
- 40,000 shares@ US$47.57Common StockSEC:0000930413-06-005542:1
- 40,000 shares@ US$1.30Common StockSEC:0000930413-06-003486:0
- 40,000 shares@ US$41.94Common StockSEC:0000930413-06-003486:1
- 5,000 shares@ US$6.36Common StockSEC:0001257957-06-000016:0Canonical exit: 15 Jun 2006 (T+90)
- 20,000 shares@ US$2.60Common StockSEC:0001012975-06-000041:0
- 20,000 shares@ US$70.69Common StockSEC:0001012975-06-000041:1
14 of 14 declarations
